Renaissance Technologies - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,964
+590.6%
193,474
+570.1%
0.01%
+600.0%
Q2 2023$574
-70.4%
28,874
-74.5%
0.00%
-66.7%
Q1 2023$1,942
-37.5%
113,374
-28.6%
0.00%
-25.0%
Q4 2022$3,108
-100.0%
158,800
-66.9%
0.00%
-63.6%
Q3 2022$7,658,000
+28.3%
479,800
+10.6%
0.01%
+57.1%
Q2 2022$5,970,000
+140.5%
433,900
+177.3%
0.01%
+133.3%
Q1 2022$2,482,000
-25.1%
156,500
+3.1%
0.00%
-25.0%
Q4 2021$3,314,000
-4.0%
151,799
+31.4%
0.00%0.0%
Q3 2021$3,452,000
+287.9%
115,493
+474.6%
0.00%
+300.0%
Q2 2021$890,000
-63.9%
20,100
-63.8%
0.00%
-66.7%
Q1 2021$2,467,000
+88.9%
55,590
-40.6%
0.00%
+200.0%
Q1 2020$1,306,000
+301.8%
93,600
+235.5%
0.00%
Q3 2019$325,000
+7.3%
27,900
+61.3%
0.00%
Q1 2019$303,000
-42.9%
17,301
-51.7%
0.00%
-100.0%
Q4 2018$531,000
-67.7%
35,818
-46.4%
0.00%
-50.0%
Q3 2018$1,645,000
-80.2%
66,825
-84.5%
0.00%
-60.0%
Q2 2018$8,319,000
+164.6%
431,320
+157.2%
0.01%
+66.7%
Q1 2018$3,144,000167,6750.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders